ILIKOS and Zapyrus Join Forces to Transform MedTech Business Development Teams
In an ever-evolving MedTech landscape where competition is fierce and innovation cycles are increasingly rapid, effective business development strategies are paramount. Recently, ILIKOS Consulting Group, a prominent business consultancy based in Cyprus and Greece, announced a strategic partnership with Zapyrus, a leading sales and market intelligence platform. This collaboration aims to equip MedTech Contract Research Organizations (CROs) with enhanced tools and insights crucial for seizing high-value opportunities in today’s global market.
The primary goal of this partnership is to amalgamate strategic business consulting with actionable sales and marketing intelligence. This fusion is designed to streamline the revenue generation process while maximizing deal conversions. By integrating ILIKOS’ extensive expertise in crafting tailored business development methodologies with Zapyrus’ cutting-edge market intelligence capabilities, they seek to empower MedTech business development teams to more efficiently identify and act upon significant market signals.
Elias Sayias, Founder and CEO of ILIKOS, emphasized the importance of aligning both strategy and methodology in the clinical research sector. He stated, “Too often, service providers in this industry either have the strategy or the methodology but not both working in sync.” The alliance aligns ILIKOS’ commercial strategy expertise with Zapyrus’ powerful market intelligence, giving MedTech teams a focused approach that promises maximum impact.
Zapyrus lends considerable value through its advanced platform that provides timely insights and a comprehensive understanding of critical development indicators. Equipped with this knowledge, MedTech business development teams can identify key buying signals, comprehend the competitive landscape, and conduct effective outreach strategies. The platform covers an extensive range of insights, including data on medical devices, in vitro diagnostics, and software as a medical device (SaMD) capabilities across various global markets, serving as a one-stop hub for clinical data, public relations, financial details, and proprietary predictive analytics.
Dr. Kevin Saem, Founder and Managing Director of Zapyrus, reiterated the mission of Zapyrus to empower business development professionals to obtain relevant information when it matters most. He noted that the collaboration with ILIKOS would significantly evolve the approach to business development, enabling clients to leverage crucial knowledge and translate it into effective methodologies that yield tangible results.
Established in Cyprus and Greece, ILIKOS Consulting Group specializes in providing hands-on business consultancy services to various sectors, including clinical research, biopharma, and investment firms. The consultancy is dedicated to creating and executing commercial strategies that ensure seamless business development along with optimal efficiency and alignment with the ever-changing market dynamics.
More information on ILIKOS can be found at www.goilikos.com.
Zapyrus stands out as a premier sales and market intelligence tool tailored for business development professionals within the MedTech sphere. The platform facilitates the identification and tracking of pivotal market indicators, allowing teams to enhance their outreach strategies, build solid relationships, and foster business growth.
For further details, visit www.zapyrus.com.
The partnership between ILIKOS and Zapyrus heralds a new era of capability for MedTech business development teams, blending strategic foresight with essential market intelligence to navigate the complexities of today’s competitive environment effectively.
Objectives of the Partnership
The primary goal of this partnership is to amalgamate strategic business consulting with actionable sales and marketing intelligence. This fusion is designed to streamline the revenue generation process while maximizing deal conversions. By integrating ILIKOS’ extensive expertise in crafting tailored business development methodologies with Zapyrus’ cutting-edge market intelligence capabilities, they seek to empower MedTech business development teams to more efficiently identify and act upon significant market signals.
Elias Sayias, Founder and CEO of ILIKOS, emphasized the importance of aligning both strategy and methodology in the clinical research sector. He stated, “Too often, service providers in this industry either have the strategy or the methodology but not both working in sync.” The alliance aligns ILIKOS’ commercial strategy expertise with Zapyrus’ powerful market intelligence, giving MedTech teams a focused approach that promises maximum impact.
The Power of Zapyrus' Platform
Zapyrus lends considerable value through its advanced platform that provides timely insights and a comprehensive understanding of critical development indicators. Equipped with this knowledge, MedTech business development teams can identify key buying signals, comprehend the competitive landscape, and conduct effective outreach strategies. The platform covers an extensive range of insights, including data on medical devices, in vitro diagnostics, and software as a medical device (SaMD) capabilities across various global markets, serving as a one-stop hub for clinical data, public relations, financial details, and proprietary predictive analytics.
Dr. Kevin Saem, Founder and Managing Director of Zapyrus, reiterated the mission of Zapyrus to empower business development professionals to obtain relevant information when it matters most. He noted that the collaboration with ILIKOS would significantly evolve the approach to business development, enabling clients to leverage crucial knowledge and translate it into effective methodologies that yield tangible results.
About ILIKOS Consulting Group
Established in Cyprus and Greece, ILIKOS Consulting Group specializes in providing hands-on business consultancy services to various sectors, including clinical research, biopharma, and investment firms. The consultancy is dedicated to creating and executing commercial strategies that ensure seamless business development along with optimal efficiency and alignment with the ever-changing market dynamics.
More information on ILIKOS can be found at www.goilikos.com.
About Zapyrus
Zapyrus stands out as a premier sales and market intelligence tool tailored for business development professionals within the MedTech sphere. The platform facilitates the identification and tracking of pivotal market indicators, allowing teams to enhance their outreach strategies, build solid relationships, and foster business growth.
For further details, visit www.zapyrus.com.
The partnership between ILIKOS and Zapyrus heralds a new era of capability for MedTech business development teams, blending strategic foresight with essential market intelligence to navigate the complexities of today’s competitive environment effectively.
Topics Business Technology）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.